Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy.
Saved in:
| Title: | Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy. |
|---|---|
| Authors: | Ferreri CJ; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hildebrandt MAT; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hashmi H; Medical University of South Carolina, Charleston, SC, USA., Shune LO; The University of Kansas Medical Center, Kansas City, KS, USA., McGuirk JP; The University of Kansas Medical Center, Kansas City, KS, USA., Sborov DW; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Wagner CB; The University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Kocoglu MH; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Rapoport A; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA., Atrash S; Levine Cancer Institute, Charlotte, NC, USA., Voorhees PM; Levine Cancer Institute, Charlotte, NC, USA., Khouri J; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Dima D; Cleveland Clinic Taussig Cancer Center, Cleveland, OH, USA., Afrough A; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Kaur G; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Anderson LD Jr; Myeloma, Waldenstrom's, and Amyloidosis Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA., Simmons G; Virginia Commonwealth University Massey Cancer Center, Richmond, VA, USA., Davis JA; Medical University of South Carolina, Charleston, SC, USA., Kalariya N; The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Peres LC; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Lin Y; Mayo Clinic, Rochester, MN, USA., Janakiram M; City of Hope, Duarte, CA, USA., Nadeem O; Dana-Farber Cancer Institute, Boston, MA, USA., Alsina M; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Locke FL; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Sidana S; Stanford University School of Medicine, Stanford, CA, USA., Hansen DK; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, USA. KPatel1@mdanderson.org., Castaneda Puglianini OA; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA. |
| Source: | Blood cancer journal [Blood Cancer J] 2023 Aug 09; Vol. 13 (1), pp. 117. Date of Electronic Publication: 2023 Aug 09. |
| Publication Type: | Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-023-00886-8 |
